OptimizeRx (OPRX) said Tuesday that it has appointed Ed Stelmakh as chief financial and strategic officer, evolving from his previous responsibilities as its chief financial officer and chief operations officer.
The company said Brendan Merrell has been appointed COO from his prior role as senior vice president, client strategy and program management.
OptimizeRx said it has appointed Andy D'Silva as chief business officer, and Marion Odence-Ford as chief legal and administrative officer.
In addition, OptimizeRx said Theresa Greco, as chief commercial officer, will continue the oversight of the commercial team.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。